MedPath

Reduction of agitation associated with ketamine

Phase 3
Conditions
Agitation.
Restlessness and agitation
Registration Number
IRCT20180129038549N8
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
96
Inclusion Criteria

Age over 18 years old
Receiving ketamine as an anesthetic agent for small surgeries
Patient's consent to participate in the study

Exclusion Criteria

Fever
Obesity (BMI>30)
Head trauma with loss of consciousness
Brain tumor,
Hydrocephaly
Glaucoma
Psychosis
Psychological disorders
History of using Benzodiazepine during last two weeks

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath